DASSIE, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 3.851
AS - Asia 2.010
EU - Europa 1.206
AF - Africa 490
SA - Sud America 479
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 22
Totale 8.108
Nazione #
US - Stati Uniti d'America 3.588
SG - Singapore 808
CN - Cina 319
BR - Brasile 300
IT - Italia 228
HK - Hong Kong 202
VN - Vietnam 161
DE - Germania 126
FI - Finlandia 85
PL - Polonia 66
NL - Olanda 64
FR - Francia 61
RU - Federazione Russa 57
TR - Turchia 54
SE - Svezia 49
GB - Regno Unito 48
AR - Argentina 33
BJ - Benin 29
IN - India 28
PY - Paraguay 27
IQ - Iraq 26
KR - Corea 25
AL - Albania 24
AT - Austria 24
LA - Repubblica Popolare Democratica del Laos 24
JP - Giappone 23
ZA - Sudafrica 23
BS - Bahamas 22
CA - Canada 22
MX - Messico 22
BA - Bosnia-Erzegovina 21
CI - Costa d'Avorio 21
IE - Irlanda 21
DO - Repubblica Dominicana 20
UA - Ucraina 20
VE - Venezuela 20
BB - Barbados 19
EC - Ecuador 19
EG - Egitto 19
ES - Italia 19
CM - Camerun 18
MD - Moldavia 18
RS - Serbia 18
AZ - Azerbaigian 17
CH - Svizzera 17
IL - Israele 17
PE - Perù 17
UZ - Uzbekistan 17
BF - Burkina Faso 16
EE - Estonia 16
ID - Indonesia 16
JM - Giamaica 16
JO - Giordania 16
PK - Pakistan 16
RO - Romania 16
TN - Tunisia 16
YT - Mayotte 16
CO - Colombia 15
CV - Capo Verde 15
CY - Cipro 15
DZ - Algeria 15
GP - Guadalupe 15
ML - Mali 15
MR - Mauritania 15
NP - Nepal 15
PT - Portogallo 15
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 14
BG - Bulgaria 14
LB - Libano 14
NO - Norvegia 14
RW - Ruanda 14
SO - Somalia 14
TH - Thailandia 14
BO - Bolivia 13
CD - Congo 13
CW - ???statistics.table.value.countryCode.CW??? 13
GR - Grecia 13
GT - Guatemala 13
HN - Honduras 13
HR - Croazia 13
MG - Madagascar 13
MK - Macedonia 13
MN - Mongolia 13
PS - Palestinian Territory 13
SI - Slovenia 13
UG - Uganda 13
AO - Angola 12
CZ - Repubblica Ceca 12
DK - Danimarca 12
LY - Libia 12
MA - Marocco 12
MU - Mauritius 12
NZ - Nuova Zelanda 12
SN - Senegal 12
UY - Uruguay 12
AU - Australia 11
BZ - Belize 11
IS - Islanda 11
KE - Kenya 11
Totale 7.619
Città #
Fairfield 545
Ashburn 463
Singapore 455
Woodbridge 275
Chandler 248
Hong Kong 192
Ann Arbor 188
Cambridge 188
Houston 174
Seattle 170
Santa Clara 141
Wilmington 141
Beijing 109
Boardman 76
Munich 65
Ho Chi Minh City 64
Padova 55
Los Angeles 52
Princeton 48
San Diego 47
Medford 45
Bytom 44
Istanbul 37
Helsinki 36
Des Moines 35
São Paulo 30
Dong Ket 29
New York 27
Cotonou 25
Chicago 24
Hefei 24
Buffalo 21
Vientiane 21
Abidjan 20
Bridgetown 19
Hanoi 19
Nassau 18
London 17
Baku 16
Dublin 16
Tashkent 16
Tirana 16
Turku 16
Redondo Beach 15
Amman 14
Bamako 14
Nouakchott 14
Ouagadougou 14
San Francisco 14
Kampala 13
Kigali 13
Lappeenranta 13
Milan 13
Nanjing 13
Phoenix 13
Praia 13
Tallinn 13
Ulan Bator 13
Antananarivo 12
Chisinau 12
Dakar 12
Guangzhou 12
Kingston 12
Lima 12
Nuremberg 12
Stockholm 12
Vienna 12
Willemstad 12
Ljubljana 11
Luanda 11
Phnom Penh 11
Rio de Janeiro 11
Warsaw 11
Accra 10
Brooklyn 10
Cairo 10
Dushanbe 10
Guayaquil 10
Johannesburg 10
Kathmandu 10
Montreal 10
Riga 10
Seoul 10
Tel Aviv 10
Tokyo 10
Tunis 10
Belo Horizonte 9
Castries 9
Douala 9
Kinshasa 9
Lusaka 9
Managua 9
Montevideo 9
Reykjavik 9
Roxbury 9
Skopje 9
Addis Ababa 8
Amsterdam 8
Andorra la Vella 8
Belgrade 8
Totale 4.896
Nome #
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 261
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs. 242
Insulin-like factor 3 plasma levels in acromegaly before and after somatostatin analog treatment. 205
Coronary microvascular dysfunction may be related to IGF-1 in acromegalic patients and can be restored by therapy 196
Ambulatory arterial stiffness indexes in acromegaly 185
Intracranial internal carotid artery changes in acromegaly: a quantitative magnetic resonance angiography study. 179
Ambulatory Arterial Stiffness Indexes in Cushing’s Syndrome 174
Ovarian tumors secreting insulin. 173
Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues 173
Coronary microvascular function in patients with Cushing's syndrome. 173
The paradoxical GH response at OGTT does not predict Pasireotide efficacy but matters for glucose metabolism 168
Persistent reduction of circulating myeloid calcifying cells in acromegaly. Relevance to the bone-vascular axis 166
Radiotherapy in acromegaly: Long-term brain parenchymal and vascular magnetic resonance changes 164
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity 163
Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome. 162
Sleep disorders and cognitive dysfunction in acromegaly 161
A very rare case of nonfunctioning pituitary adenoma incidentally disclosed at 18F-FDG PET/CT. 159
Obstructive Sleep Apnea in Acromegaly and the Effect of Treatment: A Systematic Review and Meta-Analysis 156
Preclinical markers of atherosclerosis in acromegaly: a systematic review and meta-analysis 155
Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study 154
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs 148
Ovarian 25OH-vitamin D production in young women affected by polycystic ovary syndrome 144
Liver Fibrosis and Steatosis in Alstrom Syndrome: A Genetic Model for Metabolic Syndrome 142
Neurocognitive assessment and DNA sequencing expand the phenotype and genotype spectrum of Alström syndrome 140
Cochlear Implants in Alström Syndrome 138
Left ventricular geometry and 24-h blood pressure profile in Cushing’s syndrome 135
Cutis verticis gyrata associated with acromegaly 135
In vitro chronic glycation induces AGEs accumulation reducing insulin stimulated glucose uptake and increasing GLP1R in adipocytes 131
Guidelines versus real life practice: the case of colonoscopy in acromegaly 129
"Exploring the role of growth hormone antagonist on adipocytes" 129
Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report 129
Consensus clinical management guidelines for Alström syndrome 120
Electrophysiological features in acromegaly: re-thinking the arrhythmic risk? 116
Pharmacological approaches to controlling cardiometabolic risk in women with pcos 116
Acromegaly and ultrasound: how, when and why? 114
The Endothelium in Acromegaly 113
Do Androgenic Pattern, Insulin State and Growth Hormone Affect Cardiorespiratory Fitness and Strength in Young Women with PCOS? 110
Defining renal phenotype in Alström syndrome 108
CARDIO-CEREBRO-VASCULAR RISK ASSESSMENT AND COMPLICATIONS IN ACROMEGALY 103
Hematopoietic stem cells and metabolic deterioration in Alström syndrome, a rare genetic model of the metabolic syndrome 97
Skin manifestations in rare types of diabetes and other endocrine conditions 97
Dome-and-dart T Waves and Hyperthyroidism - A Case Report 96
SGLT2 Inhibitors in the Management of Type 1 Diabetes (T1D): An Update on Current Evidence and Recommendations 94
GLOBAL PSYCHOLOGICAL ASSESSMENT WITH EVALUATION OF LIFE AND SLEEP QUALITY, SEXUAL AND COGNITIVE FUNCTION IN A LARGE NUMBER OF PATIENTS WITH ACROMEGALY: : A cross-sectional study 94
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY 92
GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study 89
Medical Treatment of Acromegaly: What's New? 86
Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management 86
Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up 84
En early rare MEN 1 Phenotype. 83
The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study 82
Paternal uniparental isodisomy of chromosome 2 in a patient with CNGA3-associated autosomal recessive achromatopsia 82
Oral Manifestations and Maxillo-Facial Features in the Acromegalic Patient: A Literature Review 82
The Italian registry for patients with Prader-Willi syndrome 76
Case Report:Pregnancy and birth in a mild phenotype of Alström syndrome 74
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 73
GH Excess: Medical Treatment of Acromegaly: What’s New? 71
The physiological sonographic features of the ovary in healthy subjects: a joint systematic review and meta-analysis by the Italian Society of Gynecology and Obstetrics (SIGO) and the Italian Society of Endocrinology (SIE) 70
Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy 69
ACRODAT and SAGIT for the assessment of disease activity in acromegaly: a multicenter study of the Veneto region in Italy 67
null 67
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 65
Oral Health and Quality of Life in Acromegaly: A Questionnaire-Based Study 64
Ovarian tumors secreting insulin 62
Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity 57
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 53
Defining puberty and spectrum of hypogonadism in Alström Syndrome 39
null 39
null 38
Collaboration for rare diabetes: understanding new treatment options for Wolfram syndrome 24
Infant sleep time: A comparative analysis of assessment methods 11
Totale 8.232
Categoria #
all - tutte 27.528
article - articoli 26.662
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 136
Totale 54.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021464 0 0 0 0 31 19 42 41 60 87 35 149
2021/2022640 35 80 60 35 30 35 33 57 53 29 48 145
2022/2023494 99 57 11 49 76 69 6 39 49 4 26 9
2023/2024319 9 41 55 28 24 40 11 15 16 13 26 41
2024/20251.642 4 139 55 57 224 30 108 98 129 90 278 430
2025/20263.337 400 529 931 1.144 333 0 0 0 0 0 0 0
Totale 8.232